Heart Test Laboratories
NASDAQ: HSCSWestlake, US · Texas corporation
Founders & leadership
AC
Andrew Christopher SimpsonExecutive
MT
Mark Thomas HilzExecutive
Board
KJ
Kavy JeffreyBoard director
DD
Drew DiazBoard director
Funding
SEC filings, press & company announcements$21.5M disclosed across 10 of 14 rounds · 2014–2025
- Undisclosed amountRegulation A OfferingJul 2025Source ↗
▶$1.1MraisedDec 2023 · 2 investors · Other Health CareRule 506(b)
▶$1.1MraisedDec 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian SzymczakDirector
- Andrew SimpsonExecutive Officer, Director
- Bruce BentDirector
- Mark HilzExecutive Officer, Director
- Danielle WatsonExecutive Officer
- David R. WellsDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Nov 2023
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$935KraisedDec 2023 · 1 investors · Other Health CareRule 506(b)
▶$935KraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew SimpsonExecutive Officer, Director
- Bruce BentDirector
- Brian SzymczakDirector
- Danielle WatsonExecutive Officer
- Mark HilzExecutive Officer, Director
- David R. WellsDirector
- Offering amount
- $935K
- Amount sold
- $935K
- First sale
- Nov 2023
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$1MraisedSep 2023 · 1 investors · Other Health CareRule 506(b)
▶$1MraisedSep 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark HilzExecutive Officer, Director
- David R. WellsDirector
- Danielle WatsonExecutive Officer
- Brian SzymczakDirector
- Andrew SimpsonExecutive Officer, Director
- Bruce BentDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Sep 2023
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$2MraisedDec 2021 · 18 investors · Other Health CareRule 506(b)
▶$2MraisedDec 2021 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark Thomas HilzExecutive Officer
- Offering amount
- $4.4M
- Amount sold
- $2M
- Minimum investment
- $100K
- Sales commissions
- $94.5K
- Proceeds to insiders
- $16K
- Placement agents
- The Benchmark Company
- First sale
- Oct 2021
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$640KraisedOct 2021 · 14 investors · Other Health CareRule 506(b)
▶$640KraisedOct 2021 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark Thomas HilzExecutive Officer
- Amount sold
- $640K
- Minimum investment
- $10K
- Proceeds to insiders
- $16K
- First sale
- Oct 2021
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2021 · 40 investors · Other Health Care
▶$1.1MraisedFeb 2021 · 40 investors · Other Health Care
Officers, directors & promoters on the filing
- Markq Thomas HilzExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- Minimum investment
- $10K
- First sale
- Jan 2021
- Incorporated
- Corporation, Texas
- Federal exemptions
- 04
▶$6.5MraisedDec 2019 · 50 investors · BiotechnologyRule 506(b)
▶$6.5MraisedDec 2019 · 50 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark HilzExecutive Officer
- Andrew SimpsonExecutive Officer
- John AdamsDirector
- Patrick KanouffDirector
- Brian SzymczakDirector
- John OwenDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- Minimum investment
- $1K
- Proceeds to insiders
- $400K
- First sale
- Apr 2019
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$3.9MraisedDec 2019 · 44 investors · BiotechnologyRule 506(b)
▶$3.9MraisedDec 2019 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick KanouffDirector
- John OwenDirector
- John AdamsDirector
- Mark HilzExecutive Officer
- Andrew SimpsonExecutive Officer
- Brian SzymczakDirector
- Offering amount
- $4M
- Amount sold
- $3.9M
- Minimum investment
- $1K
- Proceeds to insiders
- $400K
- First sale
- Mar 2018
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Heart Test Laboratories raised?
- Heart Test Laboratories has disclosed $21.5M raised across 10 of its 14 known rounds.
- Where is Heart Test Laboratories headquartered?
- Heart Test Laboratories is headquartered in Westlake, US.